跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
达赛畅 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Dalteparin Sodium Injection
Approved
化学药品
Dalteparin Sodium Injection
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
🇨🇳 National Medical Products Administration
Approval Date
Jan 17, 2020
Approval ID
7LeaeHQUWC2
Company
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
Type
化学药品
Approval Details
Approval Id
7LeaeHQUWC2
Approval Number
国药准字H20153024
Generic Name
达肝素钠注射液
Generic Name En
Dalteparin Sodium Injection
Brand Name
达赛畅
Drug Type
化学药品
Dosage Form
注射剂
Strength
0.2ml:5000 A XaIU
Reg Date
2020-01-17
Company Name
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
Company Address
南京高新开发区MA010-1号地
Production Company Name
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
Production Company Address
南京高新技术产业开发区学府路16号
Company Detail Path
/organization/nanjing-king-friend-biochemical-pharmaceutical-co-ltd
Production Company Detail Path
/organization/nanjing-king-friend-biochemical-pharmaceutical-co-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 17, 2020
Approval ID
7LeaeHQUWC2
Type
化学药品
Back to NMPA Approvals